Notes
National Health Service
2011–2012 British pounds
Reference
Zimovetz EA, et al. A Cost-Utility Analysis of Lisdexamfetamine Versus Atomoxetine in the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Inadequate Response to Methylphenidate. CNS Drugs : 16 Aug 2016. Available from: URL: http://doi.org/10.1007/s40263-016-0354-3
Rights and permissions
About this article
Cite this article
Lisdexamfetamine cost effective for ADHD in UK. PharmacoEcon Outcomes News 761, 22 (2016). https://doi.org/10.1007/s40274-016-3362-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3362-0